Nihon Medi-Physics Launches Diagnostic Agent For Lewy Body Dementia In Japan
This article was originally published in PharmAsia News
Executive Summary
Nihon Medi-Physics launched DATSCAN intravenous injection (Ioflupane I-123), a diagnostic agent for Lewy body dementia and Parkinson’s disease in Japan on Jan. 27.